4//SEC Filing
Novartis Institutes for BioMedical Research, Inc. 4
Accession 0000899243-18-009444
CIK 0001661998other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:24 PM ET
Size
9.1 KB
Accession
0000899243-18-009444
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2018-04-02+1,979,226→ 1,979,226 total - Conversion
Series B Preferred Stock
2018-04-02−1,979,226→ 0 total→ Common Stock (1,979,226 underlying)
Footnotes (2)
- [F1]The securities reported herein are held of record by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG. Novartis AG may therefore be deemed to have or share beneficial ownership of the Common Stock held directly by NIBRI.
- [F2]Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001673852
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:24 PM ET
- Size
- 9.1 KB